Next month Pfizer may bring corona vaccine for children of 5-11 years
US chief health officials believe that Pfizer Inc's COVID-19 vaccine could be authorized for children aged 5-11 by the end of October.
These timelines are based on the expectation that Pfizer will have enough data from clinical trials to obtain emergency use authorization (EUA) for that age group from the US Food and Drug Administration (FDA). They anticipate that the FDA can make a decision on whether the shot is safe and effective in young children within three weeks of submitting the EUA.
Millions of Americans are eagerly awaiting a vaccine for young children, especially parents whose children were infected with the Delta variant in recent weeks. According to sources, Fauci said if Pfizer submits its EUA by the end of September, the Pfizer product will be ready by October.
According to the source, Fauci said Moderna Inc. will take about three weeks longer than Pfizer to collect and analyze its data on children aged 5-11. He speculated that the decision on Moderna Shot could come around November, according to the source.